I cracked open a beer in preparation for the FDA’s (creatively named): “Public Workshop – Standards Based Approach to Analytical Performance Evaluation of Next Generation Sequencing In Vitro Diagnostic Tests”. Oh great, I expected bordem, little did I know I was in for a treat! The Precision Medicine Movement Coined (?) by the charismatic Barack Obama […]
personalized medicine
The accuracy of molecular diagnostic testing
In the era of personalized medicine, the accuracy of molecular diagnostic testing is more important now than ever. Personalized medicine, with the aid of molecular diagnostic testing, is providing the exciting possibility of cost-effective tailored therapies, based on an individual patient’s genetic code. This is particularly true in the case of cancer where a single […]
Personalized Medicine in Lung Cancer
Qiagen (NASDAQ: QGEN) received U.S. marketing (PMA) approval of its therascreen EGFR RGQ PCR Kit (therascreen EGFR test) as a companion diagnostic to guide the use of AstraZeneca’ (NYSE: AZN) IRESSA (gefitinib) in the treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC). As I wrote previously in my blog on cfDNA […]
What is Personalized Medicine?
Personalized medicine, with the aid of molecular diagnostics, is providing the exciting possibility of cost-effective tailored therapies, based on an individual patient’s genetic code. This is particularly true in the case of cancer where a single nucleotide polymorphism (SNP) out of a three billion-base genome can be the difference between having, and not having, an […]
Recent Comments